Search Results for: RELA

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
MED23 mediator complex subunit 23
  • PPARA activates gene expression
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • RSV-host interactions
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
MED7 mediator complex subunit 7
  • PPARA activates gene expression
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • RSV-host interactions
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
MEN1 menin 1
  • Formation of the beta-catenin:TCF transactivating complex
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Deactivation of the beta-catenin transactivating complex
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • RHO GTPases activate IQGAPs
  • Post-translational protein phosphorylation
  • Formation of WDR5-containing histone-modifying complexes
  • Primary hyperparathyroidism; Familial hyperparathyroidism (HRPT)
  • Adrenal carcinoma
  • Malignant islet cell carcinoma
  • Carcinoid
MEOX2 mesenchyme homeobox 2
MKRN2 makorin ring finger protein 2
MST1R macrophage stimulating 1 receptor
  • Signaling by MST1
  • Crizotinib
  • Fostamatinib
MTPN myotrophin
MX1 MX dynamin like GTPase 1
  • ISG15 antiviral mechanism
  • Interferon alpha/beta signaling
MYC MYC proto-oncogene, bHLH transcription factor
  • Transcription of E2F targets under negative control by DREAM complex
  • Signaling by ALK
  • NOTCH1 Intracellular Domain Regulates Transcription
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • MAPK6/MAPK4 signaling
  • Ub-specific processing proteases
  • Interleukin-4 and Interleukin-13 signaling
  • Cyclin E associated events during G1/S transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • RUNX3 regulates WNT signaling
  • Estrogen-dependent gene expression
  • Transcriptional regulation of granulopoiesis
  • Regulation of CDH1 mRNA translation by microRNAs
  • Regulation of NFE2L2 gene expression
  • Regulation of PD-L1(CD274) transcription
  • Acetylsalicylic acid
  • Dimethyl sulfoxide
  • Doconexent
  • Nadroparin
  • Penile cancer
  • Breast cancer
  • Laryngeal cancer
  • Oral cancer
  • Multiple myeloma
  • Kaposi's sarcoma
  • Ovarian cancer
  • Choriocarcinoma
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
  • Burkitt lymphoma
  • Small cell lung cancer
  • Osteosarcoma
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
NCOA3 nuclear receptor coactivator 3
  • PPARA activates gene expression
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • MAPK6/MAPK4 signaling
  • Estrogen-dependent gene expression
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
NCOA6 nuclear receptor coactivator 6
  • BMAL1:CLOCK,NPAS2 activates circadian expression
  • PPARA activates gene expression
  • PPARA activates gene expression
  • Transcriptional activation of mitochondrial biogenesis
  • Activation of gene expression by SREBF (SREBP)
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by PPARalpha
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Cytoprotection by HMOX1
  • Heme signaling
  • Formation of WDR5-containing histone-modifying complexes
  • Epigenetic regulation of gene expression by MLL3 and MLL4 complexes
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Expression of BMAL (ARNTL), CLOCK, and NPAS2
  • RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
NCOR2 nuclear receptor corepressor 2
  • PPARA activates gene expression
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • HDACs deacetylate histones
  • Notch-HLH transcription pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • Nuclear Receptor transcription pathway
  • SUMOylation of transcription cofactors
  • Regulation of lipid metabolism by PPARalpha
  • Loss of MECP2 binding ability to the NCoR/SMRT complex
  • Regulation of MECP2 expression and activity
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • HCMV Early Events
  • NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
  • Cytoprotection by HMOX1
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
NFE2L2 NFE2 like bZIP transcription factor 2
  • Neddylation
  • Potential therapeutics for SARS
  • Regulation of HMOX1 expression and activity
  • Heme signaling
  • KEAP1-NFE2L2 pathway
  • KEAP1-NFE2L2 pathway
  • Nuclear events mediated by NFE2L2
  • GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2
  • NFE2L2 regulating TCA cycle genes
  • NFE2L2 regulating inflammation associated genes
  • NFE2L2 regulating anti-oxidant/detoxification enzymes
  • NFE2L2 regulates pentose phosphate pathway genes
  • NFE2L2 regulating tumorigenic genes
  • NFE2L2 regulating MDR associated enzymes
  • NFE2L2 regulating ER-stress associated genes
  • Regulation of NFE2L2 gene expression
  • Regulation of NFE2L2 gene expression
  • Regulation of PD-L1(CD274) transcription
NFKB1 nuclear factor kappa B subunit 1
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Regulated proteolysis of p75NTR
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated NF-kB activation
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • PKMTs methylate histone lysines
  • Transcriptional regulation of white adipocyte differentiation
  • TAK1-dependent IKK and NF-kappa-B activation
  • Interleukin-1 processing
  • IkBA variant leads to EDA-ID
  • CLEC7A (Dectin-1) signaling
  • CD209 (DC-SIGN) signaling
  • CLEC7A/inflammasome pathway
  • MAP3K8 (TPL2)-dependent MAPK1/3 activation
  • Neutrophil degranulation
  • The NLRP3 inflammasome
  • Transcriptional Regulation by VENTX
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • HCMV Early Events
  • Purinergic signaling in leishmaniasis infection
  • SARS-CoV-1 activates/modulates innate immune responses
  • Regulation of NFE2L2 gene expression
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Regulation of PD-L1(CD274) transcription
  • Sulfasalazine
  • Donepezil
  • Pseudoephedrine
  • Pranlukast
  • Pranlukast
  • HE3286
  • P54
  • NOX-700
  • SGN-30
  • Custirsen
  • NF-kappaB Decoy
  • Andrographolide
  • Triflusal
  • Terpinen-4-ol
  • Glycyrrhizic acid
  • Fish oil
  • SC-236
NFKB2 nuclear factor kappa B subunit 2
  • RIP-mediated NFkB activation via ZBP1
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • PKMTs methylate histone lysines
  • TAK1-dependent IKK and NF-kappa-B activation
  • Interleukin-1 processing
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • Dectin-1 mediated noncanonical NF-kB signaling
  • NIK-->noncanonical NF-kB signaling
  • The NLRP3 inflammasome
  • TRAF6 mediated NF-kB activation
  • Purinergic signaling in leishmaniasis infection
  • Regulation of PD-L1(CD274) transcription
  • Sulfasalazine
  • Donepezil
  • Pranlukast
  • HE3286
  • P54
  • NOX-700
  • SGN-30
  • Custirsen
  • NF-kappaB Decoy
  • Andrographolide
  • Terpinen-4-ol
  • Glycyrrhizic acid
  • Fish oil
  • SC-236
NFKBIA NFKB inhibitor alpha
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • FCERI mediated NF-kB activation
  • TAK1-dependent IKK and NF-kappa-B activation
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • CLEC7A (Dectin-1) signaling
  • Ub-specific processing proteases
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • SARS-CoV-1 activates/modulates innate immune responses
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Acetylsalicylic acid
  • Bardoxolone methyl
  • Astaxanthin
  • Hodgkin lymphoma
  • Ectodermal dysplasia associated immunodeficiency (EDA-ID), including the following two diseases: NF-kappa-B essential modulator (NEMO) defect; Inhibitor of kappa-B (I-kappa-B) defect
NFKBIB NFKB inhibitor beta
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • TAK1-dependent IKK and NF-kappa-B activation
  • TRAF6 mediated NF-kB activation
NFKBIE NFKB inhibitor epsilon
  • Activation of NF-kappaB in B cells
  • Hodgkin lymphoma
NKRF NFKB repressing factor
NKX2-1 NK2 homeobox 1
  • Choreoathetosis, hypothyroidism, and neonatal respiratory distress

Page 6 out of 11 pages